Novavax Historical Balance Sheet

NVAX Stock

USD 7.17 0.17 2.43%

Trend analysis of Novavax balance sheet accounts such as Property Plant And Equipment Net of 315 M provides information on Novavax's total assets, liabilities, and equity, which is the actual value of Novavax to its prevalent stockholders. By breaking down trends over time using Novavax balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Novavax latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Novavax is a good buy for the upcoming year.

Novavax Inventory

9.19 Million

Build AI portfolio with Novavax Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

About Novavax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Novavax at a specified time, usually calculated after every quarter, six months, or one year. Novavax Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Novavax and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Novavax currently owns. An asset can also be divided into two categories, current and non-current.

Novavax Balance Sheet Chart

At this time, Novavax's Other Stockholder Equity is fairly stable compared to the past year. Total Liabilities is likely to rise to about 2.3 B in 2025, despite the fact that Total Stockholder Equity is likely to grow to (592.6 M).

Total Assets Total Current Liabilities Property Plant And Equipment Net Accounts Payable

Add Fundamental

Total Assets

Total assets refers to the total amount of Novavax assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Novavax books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Novavax balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Novavax are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Accounts Payable

An accounting item on the balance sheet that represents Novavax obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Novavax are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Novavax's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.At this time, Novavax's Other Stockholder Equity is fairly stable compared to the past year. Total Liabilities is likely to rise to about 2.3 B in 2025, despite the fact that Total Stockholder Equity is likely to grow to (592.6 M).

	2022	2023	2024	2025 (projected)
Cash	1.3B	568.5M	530.2M	556.7M
Accounts Payable	216.5M	132.6M	41.6M	24.9M

Cash Accounts Payable

Novavax balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Net Receivables	Non Current Liabilities Total	Intangible Assets	Short Long Term Debt Total	Common Stock Total Equity	Short Term Debt	Common Stock	Long Term Debt
Total Assets		0.74	0.94	-0.56	0.88	-0.89	-0.87	0.85	0.95	0.91	0.78	0.97	0.78	0.71	0.89	0.96	0.87	0.99	0.84	0.73	-0.47	0.61	-0.44	0.61	-0.37	0.34
Other Current Liab	0.74		0.89	-0.81	0.85	-0.71	-0.77	0.9	0.74	0.83	0.78	0.69	0.57	0.35	0.7	0.84	0.86	0.69	0.47	0.49	-0.32	0.47	-0.35	0.34	-0.26	0.06
Total Current Liabilities	0.94	0.89		-0.72	0.86	-0.91	-0.85	0.91	0.95	0.87	0.79	0.93	0.7	0.51	0.82	0.97	0.86	0.93	0.72	0.61	-0.41	0.59	-0.43	0.51	-0.36	0.23
Total Stockholder Equity	-0.56	-0.81	-0.72		-0.73	0.42	0.82	-0.55	-0.52	-0.69	-0.65	-0.54	-0.71	-0.03	-0.73	-0.77	-0.75	-0.5	-0.28	-0.67	0.37	-0.43	0.27	0.03	0.15	-0.19
Property Plant And Equipment Net	0.88	0.85	0.86	-0.73		-0.69	-0.94	0.81	0.74	0.99	0.85	0.79	0.85	0.61	0.93	0.93	1.0	0.82	0.65	0.82	-0.45	0.46	-0.43	0.42	-0.3	0.19
Net Debt	-0.89	-0.71	-0.91	0.42	-0.69		0.65	-0.83	-0.94	-0.72	-0.66	-0.91	-0.55	-0.5	-0.66	-0.83	-0.68	-0.91	-0.77	-0.39	0.24	-0.38	0.49	-0.55	0.46	-0.03
Retained Earnings	-0.87	-0.77	-0.85	0.82	-0.94	0.65		-0.69	-0.74	-0.94	-0.78	-0.83	-0.95	-0.49	-0.99	-0.95	-0.95	-0.83	-0.62	-0.91	0.51	-0.52	0.38	-0.31	0.25	-0.3
Accounts Payable	0.85	0.9	0.91	-0.55	0.81	-0.83	-0.69		0.88	0.82	0.73	0.8	0.48	0.65	0.66	0.84	0.8	0.83	0.62	0.42	-0.35	0.63	-0.4	0.69	-0.34	0.22
Cash	0.95	0.74	0.95	-0.52	0.74	-0.94	-0.74	0.88		0.78	0.68	0.96	0.59	0.61	0.74	0.9	0.73	0.96	0.77	0.52	-0.41	0.67	-0.42	0.67	-0.38	0.35
Non Current Assets Total	0.91	0.83	0.87	-0.69	0.99	-0.72	-0.94	0.82	0.78		0.88	0.82	0.84	0.66	0.94	0.94	0.99	0.86	0.72	0.82	-0.46	0.5	-0.41	0.45	-0.29	0.25
Non Currrent Assets Other	0.78	0.78	0.79	-0.65	0.85	-0.66	-0.78	0.73	0.68	0.88		0.64	0.63	0.51	0.75	0.82	0.86	0.73	0.81	0.67	-0.38	0.39	-0.42	0.19	-0.3	0.25
Cash And Short Term Investments	0.97	0.69	0.93	-0.54	0.79	-0.91	-0.83	0.8	0.96	0.82	0.64		0.76	0.59	0.85	0.93	0.78	0.98	0.75	0.66	-0.45	0.59	-0.42	0.61	-0.37	0.29
Common Stock Shares Outstanding	0.78	0.57	0.7	-0.71	0.85	-0.55	-0.95	0.48	0.59	0.84	0.63	0.76		0.39	0.97	0.84	0.85	0.73	0.53	0.94	-0.46	0.33	-0.38	0.19	-0.26	0.19
Other Current Assets	0.71	0.35	0.51	-0.03	0.61	-0.5	-0.49	0.65	0.61	0.66	0.51	0.59	0.39		0.55	0.55	0.58	0.7	0.66	0.5	-0.39	0.58	-0.28	0.82	-0.24	0.47
Other Stockholder Equity	0.89	0.7	0.82	-0.73	0.93	-0.66	-0.99	0.66	0.74	0.94	0.75	0.85	0.97	0.55		0.93	0.93	0.85	0.65	0.93	-0.51	0.49	-0.38	0.36	-0.26	0.3
Total Liab	0.96	0.84	0.97	-0.77	0.93	-0.83	-0.95	0.84	0.9	0.94	0.82	0.93	0.84	0.55	0.93		0.93	0.94	0.74	0.79	-0.49	0.61	-0.43	0.46	-0.33	0.33
Property Plant And Equipment Gross	0.87	0.86	0.86	-0.75	1.0	-0.68	-0.95	0.8	0.73	0.99	0.86	0.78	0.85	0.58	0.93	0.93		0.81	0.64	0.82	-0.44	0.45	-0.43	0.39	-0.3	0.18
Total Current Assets	0.99	0.69	0.93	-0.5	0.82	-0.91	-0.83	0.83	0.96	0.86	0.73	0.98	0.73	0.7	0.85	0.94	0.81		0.85	0.68	-0.46	0.62	-0.43	0.64	-0.38	0.36
Net Receivables	0.84	0.47	0.72	-0.28	0.65	-0.77	-0.62	0.62	0.77	0.72	0.81	0.75	0.53	0.66	0.65	0.74	0.64	0.85		0.57	-0.34	0.42	-0.48	0.42	-0.43	0.36
Non Current Liabilities Total	0.73	0.49	0.61	-0.67	0.82	-0.39	-0.91	0.42	0.52	0.82	0.67	0.66	0.94	0.5	0.93	0.79	0.82	0.68	0.57		-0.55	0.47	-0.3	0.2	-0.17	0.45
Intangible Assets	-0.47	-0.32	-0.41	0.37	-0.45	0.24	0.51	-0.35	-0.41	-0.46	-0.38	-0.45	-0.46	-0.39	-0.51	-0.49	-0.44	-0.46	-0.34	-0.55		-0.54	0.13	-0.27	0.08	-0.53
Short Long Term Debt Total	0.61	0.47	0.59	-0.43	0.46	-0.38	-0.52	0.63	0.67	0.5	0.39	0.59	0.33	0.58	0.49	0.61	0.45	0.62	0.42	0.47	-0.54		-0.05	0.63	-0.03	0.86
Common Stock Total Equity	-0.44	-0.35	-0.43	0.27	-0.43	0.49	0.38	-0.4	-0.42	-0.41	-0.42	-0.42	-0.38	-0.28	-0.38	-0.43	-0.43	-0.43	-0.48	-0.3	0.13	-0.05		-0.29	0.98	0.08
Short Term Debt	0.61	0.34	0.51	0.03	0.42	-0.55	-0.31	0.69	0.67	0.45	0.19	0.61	0.19	0.82	0.36	0.46	0.39	0.64	0.42	0.2	-0.27	0.63	-0.29		-0.32	0.37
Common Stock	-0.37	-0.26	-0.36	0.15	-0.3	0.46	0.25	-0.34	-0.38	-0.29	-0.3	-0.37	-0.26	-0.24	-0.26	-0.33	-0.3	-0.38	-0.43	-0.17	0.08	-0.03	0.98	-0.32		0.09
Long Term Debt	0.34	0.06	0.23	-0.19	0.19	-0.03	-0.3	0.22	0.35	0.25	0.25	0.29	0.19	0.47	0.3	0.33	0.18	0.36	0.36	0.45	-0.53	0.86	0.08	0.37	0.09

Click cells to compare fundamentals

Novavax Account Relationship Matchups

Novavax balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.6B	2.6B	2.3B	1.8B	1.6B	1.6B
Other Current Liab	(327.6M)	709.8M	1.5B	1.3B	437.8M	459.7M
Total Current Liabilities	322.0M	2.4B	2.5B	1.6B	1.2B	1.2B
Total Stockholder Equity	627.2M	(351.7M)	(634.1M)	(716.9M)	(623.8M)	(592.6M)
Property Plant And Equipment Net	180.0M	228.7M	400.5M	491.0M	300.0M	315.0M
Net Debt	(231.4M)	(1.1B)	(787.1M)	(339.4M)	(299.8M)	(284.8M)
Retained Earnings	(1.9B)	(3.6B)	(4.3B)	(4.8B)	(5.0B)	(4.8B)
Accounts Payable	54.3M	127.1M	216.5M	132.6M	41.6M	24.9M
Cash	553.4M	1.5B	1.3B	568.5M	530.2M	556.7M
Non Current Assets Total	334.3M	421.6M	555.3M	711.5M	431.5M	453.0M
Non Currrent Assets Other	13.2M	56.7M	28.5M	88.1M	24M	25.2M
Cash And Short Term Investments	711.0M	1.5B	1.3B	568.5M	923.1M	969.3M
Common Stock Shares Outstanding	57.6M	74.4M	78.2M	100.8M	152.2M	159.8M
Liabilities And Stockholders Equity	1.6B	2.6B	2.3B	1.8B	1.6B	1.6B
Other Current Assets	441.8M	176.1M	247.5M	236.4M	88.8M	57.0M
Other Stockholder Equity	2.5B	3.3B	3.6B	4.1B	4.4B	4.6B
Total Liab	955.3M	2.9B	2.9B	2.5B	2.2B	2.3B
Property Plant And Equipment Gross	180.0M	258.6M	447.8M	566.0M	349.2M	366.6M
Total Current Assets	1.2B	2.2B	1.7B	1.1B	1.1B	1.2B
Accumulated Other Comprehensive Income	7.0M	(1.4M)	(6.4M)	2.7M	(22.6M)	(21.4M)
Net Receivables	262.0M	455.0M	82.4M	297.2M	108.3M	113.7M
Non Current Liabilities Total	633.2M	538.1M	432.8M	937.1M	1.0B	1.1B
Intangible Assets	6.5M	5.6M	5.7M	4.8M	4.3M	4.1M
Short Long Term Debt Total	322.0M	454.0M	549.8M	229.1M	230.4M	145.1M
Common Stock Total Equity	3.8M	324K	714K	764K	878.6K	1.3M
Short Term Debt	322.0M	130.5M	352.1M	5.1M	7.0M	6.7M
Common Stock	714K	764K	868K	1.4M	1.6M	1.3M
Long Term Debt	322.0M	323.5M	166.5M	168.0M	169.7M	117.4M
Inventory	(166.7M)	(2.0B)	36.7M	41.7M	8.7M	9.2M
Property Plant Equipment	11.4M	180.0M	228.7M	400.5M	460.6M	483.6M
Other Liab	2.6M	3.4M	175.5M	185.0M	212.8M	223.4M
Current Deferred Revenue	273.2M	1.4B	370.1M	241.3M	675.1M	708.8M
Other Assets	5.4M	16.6M	28.5M	(57.9M)	(52.1M)	(49.5M)
Good Will	135.4M	131.5M	126.3M	127.5M	107.5M	65.4M
Short Term Investments	22.0M	0.0	157.6M	10.4M	392.9M	412.5M
Net Tangible Assets	(242.8M)	486.1M	(487.9M)	(760.4M)	(684.4M)	(650.1M)
Retained Earnings Total Equity	(1.3B)	(1.4B)	(1.9B)	(3.6B)	(3.3B)	(3.1B)
Long Term Debt Total	319.2M	320.6M	322.0M	323.5M	372.0M	234.9M
Capital Surpluse	1.1B	1.3B	2.5B	3.4B	3.9B	4.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Novavax Historical Balance Sheet

Novavax Inventory

9.19 Million

About Novavax Balance Sheet Analysis

Novavax Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Accounts Payable

Novavax balance sheet Correlations

Novavax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novavax balance sheet Accounts

Also Currently Popular

Additional Tools for Novavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Current Assets	+ 0.98	Cash And Short Term Investments
Common Stock	+ 0.98	Common Stock Total Equity

Other Stockholder Equity	- 0.99	Retained Earnings
Property Plant And Equipment Gross	- 0.95	Retained Earnings
Total Liab	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Non Current Assets Total	- 0.94	Retained Earnings
Cash	- 0.94	Net Debt